Weekly LYN-005 Provides Sustained Risperidone Release in Schizophrenia
Physician's Weekly
JUNE 18, 2025
WEDNESDAY, June 18, 2025 (HealthDay News) — For patients with schizophrenia, weekly LYN-005 provides sustained release of risperidone at therapeutic concentrations, according to a study published online June 11 in The Lancet Psychiatry. Leslie Citrome, M.D., for C min at week 1 and 1.04, 0.84, and 1.03 All rights reserved.
Let's personalize your content